Methods for the treatment of non-IgE-mediated diseases

Details Methods for the treatment of non-IgE-mediated diseases Methods for the treatment of non-IgE-mediated diseases

1992-09-08

1995-11-21

Warden, Jill

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530330, A61K 3800, C07K 500, C07K 700, C07K 1700

Patent

active

054687306

ABSTRACT:
Methods and compositions for the treatment of non-Ige-mediated inflammatory response or disease conditions are described.

REFERENCES:
patent: 4161522 (1979-07-01), Hamburger
patent: 4171299 (1979-10-01), Hamburger
patent: 4628045 (1986-12-01), Hahn
patent: 4816449 (1989-03-01), Hahn
patent: 4816449 (1989-03-01), Hahn
patent: 5061692 (1991-10-01), Hahn
patent: 5110795 (1992-05-01), Hahn
Merrifield, J. Am. Chem. Soc., 85, 2149-2154 (1963).
Crunkhorn, et al., Br. J. Pharmac. 42:392 (1971).
Meienhofer, "Hormonal Proteins and Peptides," ed. C. H. Li, vol. 2, pp. 48-267 (Academic Press, 1973).
LaGrange, et al., J. Exp. Med 139:528 (1974).
Hamburger, Science 189:389 (1975).
Hodgson, et al., Gut 19:225 (1978).
Barany and Merrifield "The Peptides," eds. E. Gross and J. Meienhofer, vol. 2, pp. 3-285 (Academic Press, 1980).
Thomson, et al., "Agents and Actions", 11:265 (1981).
Kaplan, "Allergy: Principles and Practice", eds. Middleton, E., et al., p. 1341 (2d ed. Mosey Co., St. Louis, 1983).
Gosselin, et al., editor, Clinical Toxicology of Commercial Products, pp. III-196 to III-198, (5th ed., William & Wilkins, 1984).
Roitt, et al., "Immunology", C. V. Mosby, N.Y., p. 19.1 (1985).
Baker, et al., Fd. Chem. Toxic 24:891 (1986).
Blackham, et al., British J. Pharm. 89:6954 (1986).
Walsh, et al., British J. Pharm. 91:294 (1987).
Walsh and Zeitlin, British J. Pharm. 92:741 (1987).
Martin, "Remington's Pharmaceutical Sciences".

Affiliated with

Also associated with

Rating

Methods for the treatment of non-IgE-mediated diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for the treatment of non-IgE-mediated diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of non-IgE-mediated diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1137176